DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
-22.69%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$116M
AUM Growth
+$116M
Cap. Flow
+$13.8M
Cap. Flow %
11.87%
Top 10 Hldgs %
40.13%
Holding
99
New
22
Increased
22
Reduced
12
Closed
5

Top Buys

1
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$3.94M
2
DERM
Dermira, Inc.
DERM
$3.55M
3
NBIX icon
Neurocrine Biosciences
NBIX
$3.02M
4
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
$3M
5
NVAX icon
Novavax
NVAX
$2.86M

Top Sells

1
WINT
Windtree Therapeutics Inc
WINT
$11.6M
2
CRDC
CARDICA INC COM NEW (DE)
CRDC
$4.49M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.93M
4
RIOT icon
Riot Platforms
RIOT
$1.41M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
$725K

Sector Composition

1 Healthcare 73.43%
2 Financials 0.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PVLA
76
Palvella Therapeutics, Inc. Common Stock
PVLA
$575M
$95K 0.08%
+50,214
New +$95K
GNVC
77
DELISTED
GenVec, Inc.
GNVC
$77K 0.07%
95,800
– –
CVM icon
78
CEL-SCI Corp
CVM
$80.6M
$68K 0.06%
127,482
– –
SRRA
79
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$67K 0.06%
10,000
– –
AKTX
80
Akari Therapeutics
AKTX
$21M
$66K 0.06%
4,741
-3,600
-43% -$50.1K
GLMD icon
81
Galmed Pharmaceuticals
GLMD
$7.07M
$66K 0.06%
13,488
+1,500
+13% +$7.34K
ALPN
82
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$63K 0.05%
15,000
– –
CHEKW
83
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
$42K 0.04%
53,690
-73
-0.1% -$57
ATRS
84
DELISTED
Antares Pharma, Inc.
ATRS
$39K 0.03%
45,000
– –
NDRM
85
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$17K 0.01%
+1,202
New +$17K
TRVN
86
DELISTED
Trevena, Inc.
TRVN
– –
-14,800
Closed -$155K
ARNA
87
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-381,600
Closed -$725K
CTIC
88
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-3,195,381
Closed -$3.93M
ETRM
89
DELISTED
EnteroMedics Inc.
ETRM
– –
-500,000
Closed -$65K
1 2 3
4